Semaglutide Shows Promise in Enhancing Mobility for Individuals with Peripheral Artery Disease and Type 2 Diabetes Table of Contents Semaglutide Shows Promise in Enhancing Mobility for Individuals with Peripheral Artery …
Tag:
dermatology
-
-
New research is providing clinicians with an overview of the role of immunosuppression therapy in non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (ILD).1 The data were presented at the American …
-
Pioneering Skincare: How Personal Drive is Fueling a New Era in Dermatological Solutions Table of Contents Pioneering Skincare: How Personal Drive is Fueling a New Era in Dermatological Solutions From …
-
Promising New Treatment on the Horizon for night Vision Disturbances After Refractive Surgery Table of Contents Promising New Treatment on the Horizon for night Vision Disturbances After Refractive Surgery Understanding …
-
Nadia Baichoo, MA Credit: Orlin & Cohen Main barriers to obtaining epinephrine autoinjectors for food allergies include drug shortages and high costs, a recent study found.1 “This study provides insight …
-
Monocyte-to-HDL-C ratio (MHR) was found to be correlated with gout risk and renal dysfunction severity in a new cross-sectional study.1 “High monocyte counts and low HDL-C levels positively correlate with …
-
Emerging Anemia Treatments for Dialysis Patients: A Closer Look at HIF-PHIs March 26, 2025 For over 500,000 Americans on dialysis because of chronic kidney disease (CKD), anemia remains a significant …
-
Dr. Anya Sharma on Groundbreaking Medical Innovations: A Sneak Peek into Future Healthcare In a compelling interview with Dr. Anya Sharma, Chief Medical Officer at Global Health Innovations, we delve …
-
Revolutionizing Cancer Treatment: The Rise of IgE Antibodies Against HER2-Expressing Cancers In the realm of oncology, groundbreaking research is continually paving the way for more effective cancer treatments. A recent …
-
Growing Concerns: GLP-1 RAs and the Link to Thyroid Cancer The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in treating type 2 diabetes (T2D) has exploded in recent years. …